OverviewChartNewsTraderScreen

Soc. Generale Call 185 ABBV 21.06.../  DE000SQ3S3H8  /

Frankfurt Zert./SG
2024-05-13  9:39:21 PM Chg.+0.005 Bid9:59:18 PM Ask9:59:18 PM Underlying Strike price Expiration date Option type
0.023EUR +27.78% 0.020
Bid Size: 10,000		 0.032
Ask Size: 10,000		 AbbVie Inc 185.00 USD 2024-06-21 Call
GlobeNewswire 12:14 AM In NCLA Amicus Win, and FTC Amicus Loss, Second Circuit Upholds Decision Dismissing Antitrust Suit
GlobeNewswire 05-13 Royalty Pharma to Present at Upcoming Investor Conferences
GlobeNewswire 05-11 SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LABP, DOMA, FXNC
GlobeNewswire 05-09 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 05-09 Royalty Pharma Reports First Quarter 2024 Results
GlobeNewswire 05-09 Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
GlobeNewswire 05-09 Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...
GlobeNewswire 05-08 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Alector Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 05-08 Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
GlobeNewswire 05-08 ArriVent BioPharma Reports First Quarter 2024 Financial Results
GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 05-07 Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-06 Pacific Software Inc. Announces a Landmark Asset Acquisition from Dreamaderm Inc.
GlobeNewswire 05-02 Genmab Announces Financial Results for the First Quarter of 2024
GlobeNewswire 05-02 Aprea Therapeutics Announces Appointment of Nadeem Q. Mirza, M.D., M.P.H. as Chief Medical Officer a...
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 04-30 CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Cerevel Therapeutics Holdings,...
GlobeNewswire 04-30 U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentratio...
GlobeNewswire 04-25 Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
GlobeNewswire 04-25 Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
GlobeNewswire 04-23 Leaders from Fortune 100 Best Companies to Work For To Share Insights at For All Summit May 7-9